$4,760.31 travel Payment -- Gilead Sciences to Dr. Amanda Lewis

Payment Details

AI-Powered Analysis of This Payment

The following analysis was generated by artificial intelligence to help patients understand the context, significance, and implications of this pharmaceutical payment. This analysis is not medical or legal advice.

Gilead Sciences made a $4.8K travel payment to Amanda Lewis, a Infectious Disease specialist in Fort Lauderdale, FL. The payment of $4,760.31 to Dr. Amanda Lewis from Gilead Sciences in July 2024 was for travel and lodging. This payment falls under the 'travel' category, indicating expenses related to attending events or meetings. The payment was made by Gilead Sciences, a major pharmaceutical company.

Patient Guidance: What This Payment Means for You

This payment was for travel and lodging expenses, which may be related to educational events or professional development. Always discuss your treatment options with your healthcare provider and ask about alternatives.

Payment Context: Is This Amount Normal?

Payments for travel and lodging to Infectious Disease specialists can vary widely depending on the nature of the event or research supported by the pharmaceutical company.

Regulatory Context: Sunshine Act Requirements

This payment is reported under the Sunshine Act's Open Payments program, which requires disclosure of payments made by drug and device manufacturers to physicians and teaching hospitals.

Related Topics

This payment is related to the following healthcare transparency topics:

• pharmaceutical-payments
• physician-compensation
• travel-expenses
• gilead-sciences
• infectious-disease
• open-payments

Understanding travel Payments

Travel and lodging payments cover transportation and accommodation expenses for physicians attending conferences, advisory board meetings, or speaking engagements sponsored by pharmaceutical companies. These payments can be substantial, particularly for international travel or multi-day events.

Frequently Asked Questions About This Payment

What was this $4.8K payment for?

This was a travel payment of $4.8K from Gilead Sciences to Amanda Lewis, categorized as "Travel and Lodging". The payment was reported under the Sunshine Act (CMS Open Payments).

Does Amanda Lewis accept pharmaceutical money?

Yes, Amanda Lewis received this $4.8K payment from Gilead Sciences. Under the Sunshine Act, pharmaceutical companies must report all payments to physicians exceeding $10. You can view Amanda Lewis's full payment history on the CMS Open Payments database or on this site.

Is it legal for doctors to accept pharma payments?

Yes, it is legal for physicians to receive payments from pharmaceutical companies. The Physician Payments Sunshine Act (2010) requires transparency by mandating that companies report all payments exceeding $10 to CMS. These payments include consulting fees, meals, travel, speaking fees, and research grants. The law does not prohibit payments but ensures public disclosure.

Should I be concerned about this travel payment?

A travel payment of $4.8K should be evaluated in context. Payment does not imply wrongdoing, but patients have the right to ask their doctor about pharmaceutical relationships.

How do I talk to my doctor about pharma relationships?

You can ask your doctor directly: "Do you receive payments from pharmaceutical companies?" and "Does this affect which medications you prescribe?" Most doctors will answer honestly. You can also verify payment data yourself through CMS Open Payments (openpaymentsdata.cms.gov). Consider asking about generic alternatives and whether the prescribed medication is the best option regardless of manufacturer relationships.

What types of pharma payments are most concerning?

Ownership interests and large consulting/speaking fees are generally considered more significant than meals or small educational grants. Research payments typically fund clinical studies and are common in academic medicine. The total volume and concentration of payments from a single company may be more telling than any individual payment. Patterns matter more than individual transactions.

Does pharma money affect what my doctor prescribes?

Research shows that even small payments can influence prescribing behavior. Studies published in JAMA Internal Medicine found that physicians who received meals costing as little as $20 were more likely to prescribe the promoted brand-name drug. However, many physician-industry interactions are legitimate professional activities. The key is transparency and awareness.

How does this compare to other doctors in Infectious Disease?

To compare this payment against Infectious Disease averages, check the full specialty breakdown on CMS Open Payments. Payment amounts vary widely by specialty and type. Infectious Disease physicians may receive payments for consulting, speaking, or research that are standard for the field. Individual payments should be evaluated in the context of the doctor's full payment history.

What does this payment reveal about Amanda Lewis's relationship with Gilead Sciences?

The payment amount is substantial for travel and lodging, suggesting a multi-day event or significant travel distance. This $4.8K travel payment is part of the transparency data reported under the Sunshine Act.

Is this payment amount typical for Infectious Disease?

The payment was made by a pharmaceutical company, which is common for industry-sponsored educational events or research.

What should patients do after learning about this payment?

This payment was for travel and lodging expenses, which may be related to educational events or professional development.

What else should I know about this travel payment?

Dr. Lewis's specialty is Infectious Disease, a field where pharmaceutical companies often engage in research and education.

Related Reports

• View Dr. Amanda Lewis's full payment report
• Gilead Sciences full spending report
• Browse all Infectious Disease payments
• Browse all payments in Florida
• Search for other payments